H.R. 3884 · 118th Congress

Sickle Cell Disease and Other Heritable Blood Disorders Research, Surveillance, Prevention, and Treatment Act of 2023

Introduced on Jun 7, 2023 by Michael C. Burgess (R-TX-26). 3 cosponsors, 2 of them from another party. Latest action (Sep 24, 2024): Received in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

Stage
Passed one chamber
Introduced
Jun 7, 2023
Cosponsors
3
2 from the other party
Policy area
Health
Open in the Congress explorerCongress.govAlert me

Progress

The furthest stage the measure reached. Simple and concurrent resolutions do not go to the President.

  1. Introduced
  2. Reported by committee
  3. Passed one chamber
  4. 4Passed both chambers
  5. 5Sent to the President
  6. 6Became law

Official title

To amend title XI of the Public Health Service Act to reauthorize the program providing for sickle cell disease and other heritable blood disorders research, surveillance, prevention, and treatment.

Subjects

  • Blood and blood diseases
  • Health programs administration and funding
  • Health promotion and preventive care
  • Hereditary and development disorders
  • Medical research

Summary

The Congressional Research Service has not summarized this measure yet.

Sponsor and cosponsors

Cosponsors by party as of the day they signed on. Original cosponsors signed on the day of introduction.

Michael C. BurgessR-TX-26Sponsor

Democrats · 2

Republicans · 1

Roll calls

Recorded votes on the measure. Most measures move by voice vote or unanimous consent, which record no individual positions.

No recorded roll call on this measure: it moved by voice vote or unanimous consent, or has not reached the floor.

History

Every action as published, oldest first. Roll calls link to how each member voted.

  1. Jun 7, 2023Introduced in House
  2. Jun 7, 2023Introduced in House
  3. Jun 7, 2023 · HouseReferred to the House Committee on Energy and Commerce.
  4. Jun 9, 2023 · HouseReferred to the Subcommittee on Health.
  5. Jul 13, 2023 · HouseForwarded by Subcommittee to Full Committee (Amended) by the Yeas and Nays: 28 - 0.
  6. Jul 13, 2023 · HouseSubcommittee Consideration and Mark-up Session Held
  7. Jul 19, 2023 · HouseCommittee Consideration and Mark-up Session Held.
  8. Jul 19, 2023 · HouseOrdered to be Reported (Amended) by the Yeas and Nays: 50 - 0.
  9. Aug 25, 2023Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 118-166.
  10. Aug 25, 2023 · HouseReported (Amended) by the Committee on Energy and Commerce. H. Rept. 118-166.
  11. Aug 25, 2023 · HousePlaced on the Union Calendar, Calendar No. 132.
  12. Sep 23, 2024 · HouseMr. Bucshon moved to suspend the rules and pass the bill, as amended.
  13. Sep 23, 2024 · HouseConsidered under suspension of the rules. (consideration: CR H5578-5580)
  14. Sep 23, 2024 · HouseDEBATE - The House proceeded with forty minutes of debate on H.R. 3884.
  15. Sep 23, 2024Passed/agreed to in House: On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote. (text: CR H5578)
  16. Sep 23, 2024 · HouseOn motion to suspend the rules and pass the bill, as amended Agreed to by voice vote. (text: CR H5578)
  17. Sep 23, 2024 · HouseMotion to reconsider laid on the table Agreed to without objection.
  18. Sep 24, 2024 · SenateReceived in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

Committees

Committees and subcommittees the measure was referred to.

Agencies in its committees' jurisdiction

Analisa's mapping of committee jurisdiction to federal agencies; the bill may touch others, or none of these.

Who lobbied on it

Organizations whose lobbying reports (LD-2) name this measure. Spending is what they reported for those quarters on all issues, not on this measure alone.

  1. The Children's Hospital of Philadelphia10 reports
    $760K reported (all issues)Federal contractor: THE CHILDREN'S HOSPITAL OF PHILADELPHIA$177.5K in contracts, FY2026AI match · 100%
  2. American Society of Hematology6 reports
    $150K reported (all issues)
  3. Children's Healthcare of Atlanta5 reports
  4. Sickle Cell Disease Association of America5 reports
    $100K reported (all issues)
  5. National Hemophilia Foundation3 reports
    $150K reported (all issues)
  6. National Bleeding Disorder Foundation (fka National Hemophilia Foundation)1 report
    $50K reported (all issues)

Reports filed in 2023, 2024.

Sources and method

Every figure on this page traces to these records.

  • Bill status: bills and resolutions, sponsors, actions, subjects and CRS summaries (U.S. Government Publishing Office (GovInfo), from Congress.gov (Library of Congress))GovInfo Bill Status bulk data (Congress.gov; summaries by the Congressional Research Service) · data current to Oct 10, 2026 · loaded Oct 10, 2026 · license: Public domain (U.S. Government work, 17 U.S.C. § 105)
  • Members of Congress, their terms, committees and identifiers (The @unitedstates project (from the Biographical Directory of the U.S. Congress, the House and the Senate))unitedstates/congress-legislators: legislators, committees and current committee membership · data current to Oct 3, 2026 · loaded Oct 3, 2026 · license: CC0 1.0 (public domain dedication)
  • House roll-call votes (Office of the Clerk, U.S. House of Representatives)Office of the Clerk, U.S. House of Representatives, roll-call vote records · data current to Oct 3, 2026 · loaded Oct 3, 2026 · license: Public domain (U.S. Government work, 17 U.S.C. § 105)
  • Senate roll-call votes and DW-NOMINATE scores (Voteview (UCLA Department of Political Science))Lewis, Jeffrey B., Keith Poole, Howard Rosenthal, Adam Boche, Aaron Rudkin, and Luke Sonnet (2026). Voteview: Congressional Roll-Call Votes Database. https://voteview.com/ · data current to Oct 3, 2026 · loaded Oct 3, 2026 · license: Free to use with the required citation
  • Lobbying disclosures (LD-1 registrations, LD-2 quarterly reports, LD-203 contribution reports) (Clerk of the U.S. House of Representatives)Clerk of the House, Lobbying Disclosure Act filings (organizations only; lobbyists' names are not loaded) · data current to Oct 10, 2026 · loaded Oct 10, 2026 · license: Public domain (U.S. Government work, 17 U.S.C. § 105)
  • Positions are shown only where a roll call recorded them; voice votes and unanimous consent record none.
  • Money and votes are shown side by side; neither explains the other.